Incretin-based therapies also promote axonal regeneration and functional neural repair after nerve injury [62, 63] and trigger neurogenesis and the proliferation of neuronal progenitors in the subventricular zone [64], processes that may be critical in recovery of consciousness from severe brain injuries. The gene discussed is GCG; the disease is brain injury.